In fact, loss of HER2-positive status can occur in metastatic tumors from patients with primary HER2-positive breast cancer [38], probably due to eradication of the HER2-positive major clone and secondary expansion of a minor clone lacking HER2 gene amplification. Here, ERBB2 is linked to breast cancer.